Market Trends: Nvidia valuation, biotech shifts, and the rise of thematic ETFs

Various market sectors are seeing significant movement, particularly in technology, biotechnology, and investment vehicles like exchange-traded funds (ETFs).

Nvidia is currently trading at its lowest price in five years, at under 33 times trailing 12-month earnings, as it prepares to report fiscal 2027 second-quarter results. The company remains a leader in AI infrastructure, benefiting from massive global spending by hyperscalers. In the biotechnology sector, BioNTech shares rose 7.4% following renewed investor interest in mRNA-based cancer vaccines, a trend also seen with Moderna. Meanwhile, Novavax shares saw a 6.9% increase, despite mixed analyst ratings and recent earnings that beat consensus estimates.

In the realm of investment strategies, the number of ETFs on U.S. exchanges has surpassed the number of individual stocks. Thematic ETFs are increasingly used to target trends like AI data center infrastructure. Additionally, Vanguard ETFs are highlighted as tools for simplified investing, such as the Vanguard Australian Shares Index ETF for broad domestic exposure and the Vanguard MSCI Index International Shares ETF for global market access.